Literature DB >> 33815668

Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.

Gerardo Botti1, Maurizio Di Bonito2, Monica Cantile2.   

Abstract

The growing need for personalized medicine for cancer patients has enhanced and optimized the production of living tumor organoids that have become optimal preclinical models for the discovery and screening of anticancer drugs. The systematic collection and storage of tumor organoids through the establishment of dedicated biobanks will represent a fundamental tool for cancer research and clinical trials. IJPPP
Copyright © 2021.

Entities:  

Keywords:  Organoids; biobank; precision medicine

Year:  2021        PMID： 33815668      PMCID： PMC8012858     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN： 1944-8171


  32 in total

Review 1.  Stem cell-derived organoids and their application for medical research and patient treatment.

Authors:  Sina Bartfeld; Hans Clevers
Journal:  J Mol Med (Berl)       Date:  2017-04-08       Impact factor: 4.599

2.  Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response.

Authors:  Jihyun Kim; Doyeong Yu; Youngmee Kwon; Keun Seok Lee; Sung Hoon Sim; Sun-Young Kong; Eun Sook Lee; In Hae Park; Charny Park
Journal:  Mol Cancer Res       Date:  2019-11-08       Impact factor: 5.852

Review 3.  Human tissues in a dish: The research and ethical implications of organoid technology.

Authors:  Annelien L Bredenoord; Hans Clevers; Juergen A Knoblich
Journal:  Science       Date:  2017-01-20       Impact factor: 47.728

Review 4.  In vitro human cell line models to predict clinical response to anticancer drugs.

Authors:  Nifang Niu; Liewei Wang
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

5.  A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening.

Authors:  Helen H N Yan; Hoi Cheong Siu; Simon Law; Siu Lun Ho; Sarah S K Yue; Wai Yin Tsui; Dessy Chan; April S Chan; Stephanie Ma; Ka On Lam; Sina Bartfeld; Alice H Y Man; Bernard C H Lee; Annie S Y Chan; Jason W H Wong; Priscilla S W Cheng; Anthony K W Chan; Jiangwen Zhang; Jue Shi; Xiaodan Fan; Dora L W Kwong; Tak W Mak; Siu Tsan Yuen; Hans Clevers; Suet Yi Leung
Journal:  Cell Stem Cell       Date:  2018-10-18       Impact factor: 24.633

6.  Organoid cultures derived from patients with advanced prostate cancer.

Authors:  Dong Gao; Ian Vela; Andrea Sboner; Phillip J Iaquinta; Wouter R Karthaus; Anuradha Gopalan; Catherine Dowling; Jackline N Wanjala; Eva A Undvall; Vivek K Arora; John Wongvipat; Myriam Kossai; Sinan Ramazanoglu; Luendreo P Barboza; Wei Di; Zhen Cao; Qi Fan Zhang; Inna Sirota; Leili Ran; Theresa Y MacDonald; Himisha Beltran; Juan-Miguel Mosquera; Karim A Touijer; Peter T Scardino; Vincent P Laudone; Kristen R Curtis; Dana E Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Stephen B Solomon; James A Eastham; Ping Chi; Brett Carver; Mark A Rubin; Howard I Scher; Hans Clevers; Charles L Sawyers; Yu Chen
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

7.  Prospective derivation of a living organoid biobank of colorectal cancer patients.

Authors:  Marc van de Wetering; Hayley E Francies; Joshua M Francis; Gergana Bounova; Francesco Iorio; Apollo Pronk; Winan van Houdt; Joost van Gorp; Amaro Taylor-Weiner; Lennart Kester; Anne McLaren-Douglas; Joyce Blokker; Sridevi Jaksani; Sina Bartfeld; Richard Volckman; Peter van Sluis; Vivian S W Li; Sara Seepo; Chandra Sekhar Pedamallu; Kristian Cibulskis; Scott L Carter; Aaron McKenna; Michael S Lawrence; Lee Lichtenstein; Chip Stewart; Jan Koster; Rogier Versteeg; Alexander van Oudenaarden; Julio Saez-Rodriguez; Robert G J Vries; Gad Getz; Lodewyk Wessels; Michael R Stratton; Ultan McDermott; Matthew Meyerson; Mathew J Garnett; Hans Clevers
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

Review 8.  Utilizing gastric cancer organoids to assess tumor biology and personalize medicine.

Authors:  Miranda Lin; Mei Gao; Michael J Cavnar; Joseph Kim
Journal:  World J Gastrointest Oncol       Date:  2019-07-15

9.  An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.

Authors:  Camilla Calandrini; Frans Schutgens; Rurika Oka; Thanasis Margaritis; Tito Candelli; Luka Mathijsen; Carola Ammerlaan; Ravian L van Ineveld; Sepide Derakhshan; Sanne de Haan; Emmy Dolman; Philip Lijnzaad; Lars Custers; Harry Begthel; Hindrik H D Kerstens; Lindy L Visser; Maarten Rookmaaker; Marianne Verhaar; Godelieve A M Tytgat; Patrick Kemmeren; Ronald R de Krijger; Reem Al-Saadi; Kathy Pritchard-Jones; Marcel Kool; Anne C Rios; Marry M van den Heuvel-Eibrink; Jan J Molenaar; Ruben van Boxtel; Frank C P Holstege; Hans Clevers; Jarno Drost
Journal:  Nat Commun       Date:  2020-03-11       Impact factor: 14.919

10.  Drug response in organoids generated from frozen primary tumor tissues.

Authors:  Alex J Walsh; Rebecca S Cook; Melinda E Sanders; Carlos L Arteaga; Melissa C Skala
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379
View more
  2 in total

Review 1.  Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine.

Authors:  Nicolas Germain; Melanie Dhayer; Salim Dekiouk; Philippe Marchetti
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

Review 2.  Brain and Retinal Organoids for Disease Modeling: The Importance of In Vitro Blood-Brain and Retinal Barriers Studies.

Authors:  Ilenia Martinelli; Seyed Khosrow Tayebati; Daniele Tomassoni; Giulio Nittari; Proshanta Roy; Francesco Amenta
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.